Compare Globus Medical Inc. Class A Common Stock (GMED) vs Motorola Solutions Inc (MSI) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Motorola Solutions (MSI) trades at $451.49, up 1.19% with a neutral technical outlook. The stock shows strong fundamentals with consistent earnings beats, a record $15.6B backlog (Zacks, 2026-09-28), and robust profitability (17.44% net margin). Recent acquisitions like D-Fend Solutions expand its security footprint, while a $2B share repurchase boost signals confidence. Valuation ratios remain elevated with P/E at 35.38.

Outlook is positive driven by contract wins and AI integration, but high valuation and significant investing cash outflows ($-5.16B in 2025) pose risks. Analyst consensus is bullish (70.59% Buy) with a $525.86 price target, implying 16% upside. Key risks include execution of acquisitions and debt levels (debt-to-asset 47.29% in 2025).